CBER Director Zoon To Leave FDA In Mid-January To Return To NIH
FDA will be initiating a search for a new head of the reorganized Center for Biologics Evaluation & Research following the departure of Director Kathryn Zoon, PhD, in mid-January
FDA will be initiating a search for a new head of the reorganized Center for Biologics Evaluation & Research following the departure of Director Kathryn Zoon, PhD, in mid-January